YU173088A - Process for obtaining trans-mucosalic compounds - Google Patents

Process for obtaining trans-mucosalic compounds

Info

Publication number
YU173088A
YU173088A YU01730/88A YU173088A YU173088A YU 173088 A YU173088 A YU 173088A YU 01730/88 A YU01730/88 A YU 01730/88A YU 173088 A YU173088 A YU 173088A YU 173088 A YU173088 A YU 173088A
Authority
YU
Yugoslavia
Prior art keywords
mucosalic
compounds
obtaining trans
trans
obtaining
Prior art date
Application number
YU01730/88A
Other languages
English (en)
Inventor
A R Sorensen
A Engesgaard
P E Hensen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK477487A external-priority patent/DK477487D0/da
Priority claimed from DK682587A external-priority patent/DK682587D0/da
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of YU173088A publication Critical patent/YU173088A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
YU01730/88A 1987-09-14 1988-09-14 Process for obtaining trans-mucosalic compounds YU173088A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK477487A DK477487D0 (da) 1987-09-14 1987-09-14 Praeparat
DK682587A DK682587D0 (da) 1987-12-23 1987-12-23 Praeparat til non-parenteral administration og fremgangsmaade til dets fremstilling

Publications (1)

Publication Number Publication Date
YU173088A true YU173088A (en) 1990-06-30

Family

ID=26067617

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01730/88A YU173088A (en) 1987-09-14 1988-09-14 Process for obtaining trans-mucosalic compounds

Country Status (11)

Country Link
EP (1) EP0308181A1 (cs)
JP (1) JPH03502920A (cs)
KR (1) KR890701137A (cs)
CN (1) CN1031940A (cs)
AU (1) AU2481688A (cs)
CS (1) CS274435B2 (cs)
FI (1) FI901256A0 (cs)
HU (1) HUT53281A (cs)
PT (1) PT88490B (cs)
WO (1) WO1989002279A1 (cs)
YU (1) YU173088A (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005535A1 (fr) * 1988-11-14 1990-05-31 Otsuka Pharmaceutical Co., Ltd. Preparation a base d'interferon pour administration nasale
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
GB9012663D0 (en) * 1990-06-07 1990-08-01 Erba Carlo Spa Galenic formulations containing cyclodextrins
IT1248725B (it) * 1990-06-12 1995-01-26 Sclavo Spa Composizione farmaceutica in polvere per somministrazione per via nasale contenente essenzialmente calcitonina ed un eccipiente idrosolubile
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
NL9001681A (nl) * 1990-07-24 1992-02-17 Rijksuniversiteit Transmucosale geneesmiddelpreparaten en transmucosale toediening.
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
BE1006873A6 (nl) * 1993-03-26 1995-01-10 Merkus Franciscus W H M Toedieningsformulering voor nasale insuline toediening.
IL109350A (en) * 1993-05-12 2001-01-28 Genentech Inc Stable liquid compositions of gamma interferon
WO1997033579A1 (en) * 1996-03-13 1997-09-18 Glaxo Group Limited Medicaments comprising 5ht1-like receptor agonists with an increased absorption
US6228836B1 (en) 1997-04-14 2001-05-08 Mitsubishi-Tokyo Pharmaceuticals, Inc. Permucous preparation
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
WO1999059543A1 (en) 1998-05-20 1999-11-25 Highchem Company., Ltd. A pharmaceutical formulation for nasal administration
EP0998940A1 (en) * 1998-09-30 2000-05-10 Laboratoire Theramex Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US20040258663A1 (en) * 2003-05-08 2004-12-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of interferon alpha
US20050143303A1 (en) * 2003-12-26 2005-06-30 Nastech Pharmaceutical Company Inc. Intranasal administration of glucose-regulating peptides
CN1299770C (zh) * 2004-05-31 2007-02-14 刘近周 多功能鼻腔和鼻窦洁疗液
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
SE533540C2 (sv) * 2008-12-19 2010-10-19 Neoinvent Medical Engineering Ab Administrerinssystem för administrering av en substans i munhålan
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
BR112012012475B1 (pt) 2009-11-25 2020-03-03 Boehringer Ingelheim International Gmbh Nebulizador
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
AU2014248640B2 (en) 2013-03-13 2018-03-01 Seagen Inc. Cyclodextrin and antibody-drug conjugate formulations
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
IL247927B (en) 2014-05-07 2022-09-01 Boehringer Ingelheim Int Container, a device that turns a liquid into a fine spray and use
CN116036425A (zh) 2014-05-07 2023-05-02 勃林格殷格翰国际有限公司 喷雾器、指示器装置及容器
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
BR112017014994B1 (pt) * 2015-02-17 2023-12-19 Eli Lilly And Company Composições em pó nasal para tratamento de hipoglicemia, seu uso e seus métodos de preparação, e aplicador nasal
WO2022219625A1 (en) 2021-04-11 2022-10-20 Elgan Pharma Ltd Insulin formulations and methods of using same in preterm infants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2278322A1 (fr) * 1972-12-05 1976-02-13 Ono Pharmaceutical Co Compositions contenant des prostaglandines
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
DE3302319A1 (de) * 1983-01-25 1984-08-16 Karl Eugen Prof. Dr.Med. Theurer Verfahren zur konservierung, stabilisierung und resorptionsverbesserung von therapeutisch anzuwendenden zell- und organbestandteilen
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS61126034A (ja) * 1984-11-26 1986-06-13 Yamanouchi Pharmaceut Co Ltd アルド−スを含有するカルシトニン経鼻剤
US4727077A (en) * 1985-02-20 1988-02-23 Ishihara Sangyo Kaisha Ltd. Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
JPS63196524A (ja) * 1987-02-10 1988-08-15 Wakunaga Pharmaceut Co Ltd 経粘膜吸収型制ガン作用調節剤

Also Published As

Publication number Publication date
KR890701137A (ko) 1989-12-19
CN1031940A (zh) 1989-03-29
HUT53281A (en) 1990-10-28
PT88490A (pt) 1988-10-01
EP0308181A1 (en) 1989-03-22
FI901256A7 (fi) 1990-03-13
FI901256A0 (fi) 1990-03-13
CS614388A2 (en) 1990-08-14
PT88490B (pt) 1992-11-30
JPH03502920A (ja) 1991-07-04
WO1989002279A1 (en) 1989-03-23
CS274435B2 (en) 1991-04-11
HU885826D0 (en) 1990-09-28
AU2481688A (en) 1989-04-17

Similar Documents

Publication Publication Date Title
YU40688A (en) Process for obtaining piperazinyl-heterocyclic compounds
YU173088A (en) Process for obtaining trans-mucosalic compounds
YU157188A (en) Process for obtaining 5-heterocyclical-substituted oxazolidinic dihaloacetats
YU130288A (en) Process for obtaining benzopirane derivatives
YU36388A (en) Process for obtaining antihipercholesterolic tetrazolic compounds
YU202789A (en) Process for obtaining heterocyclical compounds
YU24088A (en) Process for preparing heterocyclical compounds
YU30388A (en) Process for obtaining arylpiperazinylalkylenephenyl-heterocyclic compounds
YU217088A (en) Process for obtaining new iminophenylthiazolidins
YU55088A (en) Process for obtaining propylolephine derivatives
YU198989A (en) Process for obtaining quinolynic derivatives
EP0283905A3 (en) Process for preparing chloropolysilanes
YU234688A (en) Process for obtaining acylderivative
GB8810248D0 (en) Process for obtaining scualane
YU152088A (en) Process for obtaining beta lactamic compounds
YU183788A (en) Process for obtaining anilynofumarate
YU110888A (en) Process for obtaining timine derivatives
YU240088A (en) Process for obtaining dioxazocine derivative
HUT48257A (en) Process for producing makrolid compounds
HUT48254A (en) Process for producing macrolid compounds
PT86534A (en) Process for preparing 2-heterocyclylalkyl-2-penem compounds
YU225487A (en) Process for obtaining new cephalosporinic compounds
YU148788A (en) Process for obtaining new macrolidic compounds
CS254287A1 (en) Process for preparing alkoxyphenoles
CS93387A1 (en) Process for preparing o-chlorbenzamide